中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2012年
7期
1245-1250
,共6页
李兴国%郑宏宇%李文%李宏昆%赵学凌%吴雪梅%王兵
李興國%鄭宏宇%李文%李宏昆%趙學凌%吳雪梅%王兵
리흥국%정굉우%리문%리굉곤%조학릉%오설매%왕병
核转录因子kappa B1%组织因子%静脉内皮组织%深静脉血栓
覈轉錄因子kappa B1%組織因子%靜脈內皮組織%深靜脈血栓
핵전록인자kappa B1%조직인자%정맥내피조직%심정맥혈전
背景:目前调控静脉内皮细胞、血小板、炎性细胞之间相互作用,促进局部深静脉血栓微环境形成的机制尚不完全清楚,仍未发现早期诊断深静脉血栓的可靠方法.目的:研究核转录因子kappa B1 和组织因子在大鼠深静脉血栓形成中的作用.方法:将67 只SD 大鼠随机分为对照组和模型组,对模型组采用股静脉钳夹联合下肢石膏制动构建大鼠深静脉血栓形成模型.于造模后2.5,25 h,解剖股静脉观测血栓的发生情况,进一步将模型组分为:血栓形成前组(造模后2.5 h) 、血栓形成组和血栓不形成组(造模后25 h).取各组股静脉内皮组织,采用基因芯片筛查差异表达的基因,并进一步采用real-time PCR 进行验证.结果与结论:基因芯片分析及real-time PCR 结果均发现,造模后2.5 h,血栓形成前组大鼠股静脉内皮组织中核转录因子kappa B1 和组织因子表达明显高于对照组(P < 0.05); 造模后25 h,血栓形成组大鼠股静脉内皮组织中核转录因子kappa B1 和组织因子表达明显高于血栓形成前组、血栓不形成组和对照组(P < 0.05).提示局部静脉内皮组织中核转录因子kappa B1 和组织因子表达水平上调可能在深静脉血栓形成中发挥了重要作用.
揹景:目前調控靜脈內皮細胞、血小闆、炎性細胞之間相互作用,促進跼部深靜脈血栓微環境形成的機製尚不完全清楚,仍未髮現早期診斷深靜脈血栓的可靠方法.目的:研究覈轉錄因子kappa B1 和組織因子在大鼠深靜脈血栓形成中的作用.方法:將67 隻SD 大鼠隨機分為對照組和模型組,對模型組採用股靜脈鉗夾聯閤下肢石膏製動構建大鼠深靜脈血栓形成模型.于造模後2.5,25 h,解剖股靜脈觀測血栓的髮生情況,進一步將模型組分為:血栓形成前組(造模後2.5 h) 、血栓形成組和血栓不形成組(造模後25 h).取各組股靜脈內皮組織,採用基因芯片篩查差異錶達的基因,併進一步採用real-time PCR 進行驗證.結果與結論:基因芯片分析及real-time PCR 結果均髮現,造模後2.5 h,血栓形成前組大鼠股靜脈內皮組織中覈轉錄因子kappa B1 和組織因子錶達明顯高于對照組(P < 0.05); 造模後25 h,血栓形成組大鼠股靜脈內皮組織中覈轉錄因子kappa B1 和組織因子錶達明顯高于血栓形成前組、血栓不形成組和對照組(P < 0.05).提示跼部靜脈內皮組織中覈轉錄因子kappa B1 和組織因子錶達水平上調可能在深靜脈血栓形成中髮揮瞭重要作用.
배경:목전조공정맥내피세포、혈소판、염성세포지간상호작용,촉진국부심정맥혈전미배경형성적궤제상불완전청초,잉미발현조기진단심정맥혈전적가고방법.목적:연구핵전록인자kappa B1 화조직인자재대서심정맥혈전형성중적작용.방법:장67 지SD 대서수궤분위대조조화모형조,대모형조채용고정맥겸협연합하지석고제동구건대서심정맥혈전형성모형.우조모후2.5,25 h,해부고정맥관측혈전적발생정황,진일보장모형조분위:혈전형성전조(조모후2.5 h) 、혈전형성조화혈전불형성조(조모후25 h).취각조고정맥내피조직,채용기인심편사사차이표체적기인,병진일보채용real-time PCR 진행험증.결과여결론:기인심편분석급real-time PCR 결과균발현,조모후2.5 h,혈전형성전조대서고정맥내피조직중핵전록인자kappa B1 화조직인자표체명현고우대조조(P < 0.05); 조모후25 h,혈전형성조대서고정맥내피조직중핵전록인자kappa B1 화조직인자표체명현고우혈전형성전조、혈전불형성조화대조조(P < 0.05).제시국부정맥내피조직중핵전록인자kappa B1 화조직인자표체수평상조가능재심정맥혈전형성중발휘료중요작용.
BACKGROUND: At present, the basic underlying molecular mechanism regulating the interactions among venous endothelial cells, platelets, leukocytes, and promoting local deep vein thrombosis microenvironment formation, still remains unclear, and there is no ideal method for early diagnosis of deep vein thrombosis. OBJECTIVE: To study the underlying role of nuclear factor kappa B1 and tissue factor in rats with deep vein thrombosis. METHODS: A total of 67 Sprague-Dawley rats were randomly divided into control group (n=10) and model group (n=57). Deep vein thrombosis model was established by a clamping and sewing method in femoral vein combined with cast fixation. The incidence and serious degree of thrombus were observed by dissecting rat femoral vein in different time points (2.5 and 25 hours after modeling). The model group was further divided into pre-thrombogenesis group (2.5 hours after modeling), thrombogenesis group (25 hours after modeling) and non-thrombogenesis group (25 hours after modeling). Then total RNA was extracted from the localized femoral venous endothelial tissue. The candidate genes, associated inflammation and thrombosis, were screened by a special gene chip. Then the gene expression of nuclear factor kappa B1 and tissue factor was further identified by real-time polymerase chain reaction. RESULTS AND CONCLUSION: Pre-thrombogenesis group had no thrombogenesis, while thrombogenesis group have 23 cases with thrombosis and non-thrombogenesis group have 22 cases without thrombosis. The results of gene chip hybridization analysis and real-time PCR found that the mRNA expression of nuclear factor kappa B1 and tissue factor in rat femoral vein endothelial tissue were significantly up-regulated at 2.5 hours after modeling (pre-thrombogenesis group was higher than control group) (P < 0.05), and continued up-regulating at 25 hours after modeling (thrombogenesis group was higher than the pre-thrombogenesis group, non-thrombogenesis group and control group) (P < 0.05). The results from present study indicate that up-regulating expressions of nuclear factor kappa B1 and tissue factor in local femoral venous endothelial tissue of rat deep vein thrombosis models may play a key role in initiating venous thrombosis.